As of 2026-09-17, the Intrinsic Value of XBiotech Inc (XBIT) is -7.40 USD. This XBIT valuation is based on the model Peter Lynch Fair Value. With the current market price of 2.15 USD, the upside of XBiotech Inc is -444.25%.
Based on its market price of 2.15 USD and our intrinsic valuation, XBiotech Inc (XBIT) is overvalued by 444.25%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -7.40 - -7.40 | -7.40 | -444.25% |
| P/E | (23.24) - (31.74) | (29.09) | -1452.9% |
| DDM - Stable | (8.51) - (21.95) | (15.23) | -808.3% |
| DDM - Multi | (6.28) - (12.98) | (8.50) | -495.5% |
| Market Cap (mil) | 65.55 |
| Beta | 1.42 |
| Outstanding shares (mil) | 30.49 |
| Enterprise Value (mil) | -43.97 |
| Market risk premium | 4.60% |
| Cost of Equity | 13.12% |
| Cost of Debt | 5.00% |
| WACC | 8.96% |